Prof Ana Alfirevic MD, PhD

Professor Molecular and Clinical Pharmacology

    Research

    Research Group Membership

    Research Grants

    North West Coast CLAHRC

    DEPARTMENT OF HEALTH (UK) (NIHR), LIVERPOOL CLINICAL COMMISSIONING GROUP (UK)

    January 2014 - March 2021

    PhD Bench fees Faten Fahad I Bin Dayel - STU342

    ROYAL EMBASSY OF SAUDI ARABIA CULTURAL BUREAU IN LONDON (UK)

    October 2019 - September 2020

    NIHR Applied Research Collaboration North West Coast

    DEPARTMENT OF HEALTH (UK) (NIHR), LIVERPOOL CLINICAL COMMISSIONING GROUP (UK)

    October 2019 - September 2024

    The role of transporters in the uptake of AV-101

    VISTAGEN THERAPEUTICS, INC (USA)

    September 2017 - June 2021

    Systems pharmacology approaches to drug-induced hypersensitivity reactions

    MALAYSIAN GOVERNMENT (MALAYSIA)

    March 2015 - February 2018

    PREDICTION-ADR: Personalisation of tREatment In Cardiovascular disease through next generation sequencing in Adverse Drug Reactions

    EUROPEAN COMMISSION

    September 2013 - February 2017

    Genetic markers for carbamazepine-induced hypersensitivty syndrome

    EPILEPSY RESEARCH UK (UK)

    June 2012 - November 2013

    A pharmacogenomic approach to coumarin anticoagulant therapy (PACT)

    EUROPEAN COMMISSION

    October 2008 - March 2013

    EURIPIDES - EUropean Research initiative to develop Imaging Probes for early In-vivo Diagnosis and Evaluation of response to therapeutic Substances

    EUROPEAN COMMISSION

    February 2008 - January 2013

    Pharmacogenetics of Methadone response

    NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL (AUSTRALIA)

    September 2010 - February 2013

    Research Collaborations

    JC Smith

    External: AstraZeneca Pharmceuticals

    1)The role of HSP70 gene cluster polymorphisms in carbamazepine induced hypersensitivity reactions
    2) Genetic polymorphisms and tacrine induced hepatotoxicity